Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Team Innovation backs Odd Not Even as Karan Aujla merch goes global and 21 Savage buzz spreads

Team Innovation backs Odd Not Even as Karan Aujla merch goes global and 21 Savage buzz spreads

MUMBAI, January 12, 2026, 15:48 IST Odd Not Even, a Mumbai-based lifestyle start-up, has secured a strategic investment from events firm Team Innovation as it tries to scale a culture-led fashion label and its artist merchandise work, the company said on Monday. Financial terms were not disclosed. (IFAB MEDIA (infashionbusiness.com)) The tie-up matters now because India’s live-events circuit is running hotter and bigger, and promoters are looking past ticketing for steadier money. Merchandise — licensed T-shirts, hoodies and accessories — is one of the few add-ons that can move across cities and also sell online to fans abroad. It is
12 January 2026
TCS, HCLTech Q3 results today: The AI clues investors are watching more than the numbers

TCS, HCLTech Q3 results today: The AI clues investors are watching more than the numbers

MUMBAI, Jan 12, 2026, 15:47 IST India’s Tata Consultancy Services (TCS) and HCL Technologies (HCLTech) are set to release fiscal third-quarter results later Monday. Investors will be watching closely to see how fast artificial intelligence projects are translating into actual revenue. Focus has shifted from quarterly results to generative AI (GenAI)—tools capable of writing code and text—and whether this tech can revitalize a sector weighed down by foreign investors offloading about 750 billion rupees of Indian IT stocks in 2025. Nomura’s Abhishek Bhandari noted clients are “gradually moving from proof-of-concept projects to standalone implementations of AI.” Meanwhile, HSBC’s Yogesh Aggarwal
12 January 2026
······
Valens Semiconductor stock dips in premarket after 59% spike; VA7000 ADAS win still in focus

Valens Semiconductor stock dips in premarket after 59% spike; VA7000 ADAS win still in focus

New York, January 12, 2026, 05:49 EST — Premarket Valens Semiconductor Ltd shares dropped 4.4% to $2.37 in early Monday trading, pulling back from last week’s big surge. The stock finished Friday at $2.48, jumping 59% for the day after swinging between $1.63 and $2.72 on volume nearing 45 million shares. (StockAnalysis) The move stands out since Valens is a small, thinly traded chip stock, and the volume surge on Friday felt more like a shift in tone than a typical bounce. Investors are quick to react to any sign of broader adoption for new in-car sensor links, even if
12 January 2026
···
Exxon stock moves premarket on Trump’s Venezuela warning — what to watch before the open

Exxon stock moves premarket on Trump’s Venezuela warning — what to watch before the open

New York, Jan 12, 2026, 05:53 EST — Premarket Exxon Mobil Corp shares climbed 1.4% to $124.61 in U.S. premarket Monday. President Donald Trump suggested he could block the oil giant from investing in Venezuela, following CEO Darren Woods’ description of the country as “uninvestable.” (Reuters) Washington’s push to revive Venezuelan oil exports and lure private investment into a sector crippled by sanctions and neglect is driving the headlines. For Exxon, a comeback would put its insistence on clear rules and strong safeguards to the test — adding a political edge to a stock that’s already sensitive to crude price
12 January 2026
···
Hims & Hers Health (HIMS) stock slides premarket after Amazon’s Wegovy pill move — what traders watch next

Hims & Hers Health (HIMS) stock slides premarket after Amazon’s Wegovy pill move — what traders watch next

NEW YORK, Jan 12, 2026, 05:28 EST — Premarket Shares of Hims & Hers Health, Inc. slipped 2.2% in premarket trading Monday, hitting $31.00. The stock had already fallen 6.4% on Friday to $31.69 amid heavy volume. (StockAnalysis) The selloff late in the week came after Amazon Pharmacy began offering Novo Nordisk’s newly approved Wegovy weight-loss pill via insurance plans and a cash-pay option, opening yet another major channel in a market Hims has heavily relied on for growth. (Reuters) This is crucial now since investors see weight loss as Hims’ key growth driver: it attracts fresh users but can
12 January 2026
····
Pan American Silver PAAS stock jumps in premarket as silver smashes records — what to watch next

Pan American Silver PAAS stock jumps in premarket as silver smashes records — what to watch next

New York, Jan 12, 2026, 05:30 EST — Premarket Pan American Silver Corp shares rose 4.5% in U.S. premarket trading on Monday, lifting the stock to $56.70 as precious metals ripped higher. (Public) Silver hit fresh records as investors rushed into “hard” assets after headlines around a criminal probe involving Federal Reserve Chair Jerome Powell and a sharper geopolitical backdrop. “With the Fed’s independence now openly contested,” investors were shifting toward hard assets, said Zain Vawda, an analyst at MarketPulse by OANDA. (Reuters) Silver futures were last up about 6% on CME’s Globex session early Monday. That matters for miners
12 January 2026
·····
Tempus AI stock jumps in premarket after $1.27 billion revenue preview, contract value tops $1.1 billion

Tempus AI stock jumps in premarket after $1.27 billion revenue preview, contract value tops $1.1 billion

New York, Jan 12, 2026, 05:29 EST — Premarket Tempus AI, Inc. shares were up about 11% in premarket trading on Monday after the company flagged strong preliminary 2025 results and reported record contract value with drugmakers. Tempus AI traded at $73.66 in premarket action, after ending Friday at $66.27. (google.com) The update lands as investors head into the annual J.P. Morgan Healthcare Conference week, when companies often try to reset expectations and pitch their 2026 story. Tempus has been a high-beta name in that mix, moving sharply on growth signals. For Tempus, the market focus has narrowed to two
12 January 2026
········
Mereo BioPharma stock steadies premarket as JPM Healthcare Conference puts MREO back in play

Mereo BioPharma stock steadies premarket as JPM Healthcare Conference puts MREO back in play

New York, January 12, 2026, 05:24 EST — Premarket Mereo BioPharma Group plc shares held steady near $0.49 in U.S. premarket trading Monday, following a strong 28.6% jump to $0.4944 at Friday’s close. (The Wall Street Journal) Timing is key here. The J.P. Morgan Healthcare Conference is set for Jan. 12-15 in San Francisco, a week known for sharp moves in small biotech stocks on any news of partnerships, cost reductions, or strategic shifts. Last week, Mereo announced that CEO Denise Scots-Knight will present on Jan. 14. (JPMorgan Chase) Mereo has been struggling to bounce back since late December, when
12 January 2026
····
NovaBay Pharmaceuticals (NBY) stock slides premarket after 102% surge — dilution risk back on radar

NovaBay Pharmaceuticals (NBY) stock slides premarket after 102% surge — dilution risk back on radar

New York, January 12, 2026, 05:15 EST — Premarket NovaBay Pharmaceuticals, Inc. shares slipped roughly 10% in early Monday trading, falling to $17.21 after finishing Friday at $19.16. This dip comes after a notable surge in the lightly traded stock on the NYSE American. https://stockanalysis.com/stocks/nby/ Friday’s surge was extreme, even for a microcap. Shares closed up 102.5%, swinging between $9.69 and $19.95, on roughly 10 million shares changing hands, according to StockAnalysis data. https://stockanalysis.com/stocks/nby/history/ This is crucial now, as the stock has morphed into a momentum play within just a few sessions. Such trades hinge heavily on share availability. With
12 January 2026
·····
Barclays stock slides on Trump’s 10% credit-card rate cap call as investors size up profit hit

Barclays stock slides on Trump’s 10% credit-card rate cap call as investors size up profit hit

London, January 12, 2026, 10:13 GMT — Regular session underway. Shares of Barclays (BARC.L) in London dropped 3.5% on Monday following U.S. President Donald Trump’s push to cap credit card interest rates at 10%. Barclays’ U.S. card business ranks ninth in that market, accounting for roughly 11% of the group’s profits, said Matt Britzman, senior equity analyst at Hargreaves Lansdown. (Reuters) The shift is significant as it pulls politics directly into consumer lending, a space known for high margins but also sudden regulatory shifts that can upend the numbers. For Barclays, U.S. credit cards have been a relatively straightforward growth
12 January 2026
····
Abivax stock jumps on fresh Eli Lilly takeover talk as ABVX.PA hits record — what traders watch next

Abivax stock jumps on fresh Eli Lilly takeover talk as ABVX.PA hits record — what traders watch next

Paris, Jan 12, 2026, 11:17 CET — Regular session Shares in ABIVAX Société Anonyme surged Monday following a French media report that stirred new takeover speculation involving the biotech and U.S. pharmaceutical giant Eli Lilly. (Reuters) The stock climbed roughly 22% to 120.60 euros, hitting a peak of 130 euros earlier, based on Euronext-tracked quotes. It closed at 99 euros on Friday. (MarketScreener Canada) Why it matters now: Abivax is among the busiest biotech stocks in Paris at these levels, with even whispers of a deal sending its shares sharply higher. A one-day surge above 20% puts short-term funds on
12 January 2026
····
IREN Limited stock (NASDAQ: IREN) nudges up premarket as bitcoin steadies and CPI looms

IREN Limited stock (NASDAQ: IREN) nudges up premarket as bitcoin steadies and CPI looms

New York, Jan 12, 2026, 04:51 EST — Premarket IREN Limited’s shares ticked up roughly 0.7% to $46.03 in early premarket action Monday. The stock finds itself caught between two fast-moving trades: crypto pricing and the surge in demand for power-hungry AI computing. Tuesday at 8:30 a.m. ET brings the U.S. consumer price index report for December, a key figure that frequently shakes up rates and risk assets. Bitcoin edged up 0.1%, hovering around $90,714. Crypto-mining stocks showed a mixed bag: Marathon Digital slipped nearly 2%, while Riot Platforms and Core Scientific gained 1.3% and 2.5%, respectively. CleanSpark dropped close
12 January 2026
·····
1 … 332 333 334 335 336 … 886

Stock Market Today

Meta stock faces an AI split: ad gains vs a $135 billion bill

Meta stock faces an AI split: ad gains vs a $135 billion bill

7 February 2026
Meta shares dropped 1.3% to $661.46 on Friday after the company projected 2026 capital spending of up to $135 billion, raising investor concerns over cash flow. Meta reported Q4 revenue of $59.89 billion, up 24% year-over-year, with ad impressions rising 18%. Analysts remain divided on whether AI-driven ad gains can offset the steep spending ramp.
IAG share price jumps toward a 52-week peak — what to watch before London reopens

IAG share price jumps toward a 52-week peak — what to watch before London reopens

7 February 2026
IAG shares rose 4.33% to 438.50 pence Friday, near their 52-week high, ahead of full-year results due later this month. The company reported 162,073,135 treasury shares and total voting rights of 4,565,128,012. Brent crude fell 2.2% Thursday to $67.93 a barrel. South Europe Ground Services logged 712,340 operations in 2025 and seeks approval to operate in Portugal.
Go toTop